Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
898.15
Change Change %
8.20 0.92%

Updated:03 Dec, 2020, 15:59 PM IST

BSE
900.80
Change Change %
11.75 1.32%

Updated:03 Dec, 2020, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
JP Morgan
N/A
20-07-2016 Buy 759.30 900.00
N/A
Closed Long (1Y)
20-07-2017

JP Morgan initiates Aurobindo Pharma with overweight

JP Morgan has initiated coverage on Aurobindo Pharma with a "overweight" rating. Expect 18 per cent CAGR in earnings over FY17-19. US is a key growth driver with improved execution. Debt reduction to be key trigger over next 2 years. Estimate margin expansion of 150 basis points by FY18.

Top
Listen to the latest songs, only on JioSaavn.com